The mechanism of action of selective serotonin re-uptake inhibitors (SSRIs)

Depression is associated with reduced levels of the monoamines in the brain, such as serotonin (5-HT). The selective 5-HT re-uptake inhibitors (SSRIs) are thought to restore the levels of 5-HT in the synaptic cleft by binding at the 5-HT re-uptake transporter preventing the re-uptake and subsequent degradation of 5-HT. This re-uptake blockade leads to the accumulation of 5-HT in the synaptic cleft and the concentration of 5-HT returns to within the normal range. This action of SSRIs is thought to contribute to the alleviation of the symptoms of depression. In the presence of the SSRI, small amounts of 5-HT continue to be degraded in the synaptic cleft.

  1. Other peripheral mediators: 5-hydroxytryptamine and purines. In: Pharmacology, 4th edition. Rang HP, Dale MM and Ritter JM. Edinburgh, UK: Harcourt Publishers Ltd, 2001:165–176.
  2. Noradrenergic transmission. In: Pharmacology, 4th edition. Rang HP, Dale MM, Ritter JM and Gardner P. Edinburgh, UK: Harcourt Publishers Ltd, 2001:139–163
  3. Drugs used in affective disorders. In: Pharmacology, 4th edition. Rang HP, Dale MM, Ritter JM and Gardner P. Edinburgh, UK: Harcourt Publishers Ltd, 2001:550–565
  4. Selective Serotonin Reuptake Inhibitors (SSRI) Pathway. Sangkuhl K, Klein T, and Altman R. Pharmacogenet Genomics. 2009 November ; 19(11): 907–909
  5. Modern bioanalytical methods for the rapid detection of antidepressants: SNRIs and SSRIs in human biological samples. Samanidou V, Kourti P. Bioanalysis. 2009 May;1(2):451-88
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country